Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention (Q36966069)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 2007

Language	Label	Description	Also known as
English	Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention	scientific article published on November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

Elizabeth Selvin

2

object named as

Elizabeth Selvin

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

author name string

Sherita H Golden

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Kayla E Cunningham

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

792-798

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The effect of ruboxistaurin on nephropathy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Overview of incretin hormones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00673.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2006.00673.X

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36966069&oldid=1664643842"